Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1 | MicrobiomeTrials← Back to trialsNCT03830229
Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1
RecruitingOBSERVATIONAL
Trial Details
Start: 2019-03-13Est. Completion: 2026-07-06
Enrollment target: 1,000 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Unresectable Pleural Mesothelioma
This is a phase III, randomized, open-label, multicenter, global study to determine the efficacy and safety of Volrustom…
Santa Rosa, United StatesEst. completion Nov 16, 2028
Non-Small Cell Lung CancerSmall Cell Lung CancerExtrapulmonary Small Cell CancerPulmonary Neuroendocrine TumorsThymic Epithelial Tumors
Background:
\- Lung cancer is the leading cause of cancer-related death worldwide. It causes more than one million deat…
Bethesda, United States
Est. completion Dec 31, 2028